These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 22917585)

  • 21. Expanded polyglutamines induce neurodegeneration and trans-neuronal alterations in cerebellum and retina of SCA7 transgenic mice.
    Yvert G; Lindenberg KS; Picaud S; Landwehrmeyer GB; Sahel JA; Mandel JL
    Hum Mol Genet; 2000 Oct; 9(17):2491-506. PubMed ID: 11030754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SCA7 mouse models show selective stabilization of mutant ataxin-7 and similar cellular responses in different neuronal cell types.
    Yvert G; Lindenberg KS; Devys D; Helmlinger D; Landwehrmeyer GB; Mandel JL
    Hum Mol Genet; 2001 Aug; 10(16):1679-92. PubMed ID: 11487572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. H1152 promotes the degradation of polyglutamine-expanded ataxin-3 or ataxin-7 independently of its ROCK-inhibiting effect and ameliorates mutant ataxin-3-induced neurodegeneration in the SCA3 transgenic mouse.
    Wang HL; Hu SH; Chou AH; Wang SS; Weng YH; Yeh TH
    Neuropharmacology; 2013 Jul; 70():1-11. PubMed ID: 23347954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progressive retinal degeneration and dysfunction in R6 Huntington's disease mice.
    Helmlinger D; Yvert G; Picaud S; Merienne K; Sahel J; Mandel JL; Devys D
    Hum Mol Genet; 2002 Dec; 11(26):3351-9. PubMed ID: 12471061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insights into the molecular basis of polyglutamine neurodegeneration from studies of a spinocerebellar ataxia type 7 mouse model.
    Grote SK; La Spada AR
    Cytogenet Genome Res; 2003; 100(1-4):164-74. PubMed ID: 14526177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polyglutamine-expanded ataxin-7 causes cerebellar dysfunction by inducing transcriptional dysregulation.
    Chou AH; Chen CY; Chen SY; Chen WJ; Chen YL; Weng YS; Wang HL
    Neurochem Int; 2010 Jan; 56(2):329-39. PubMed ID: 19909779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of HGF attenuates the degeneration of Purkinje cells and Bergmann glia in a knockin mouse model of spinocerebellar ataxia type 7.
    Noma S; Ohya-Shimada W; Kanai M; Ueda K; Nakamura T; Funakoshi H
    Neurosci Res; 2012 Jun; 73(2):115-21. PubMed ID: 22426494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human cytomegalovirus UL97 kinase prevents the deposition of mutant protein aggregates in cellular models of Huntington's disease and ataxia.
    Tower C; Fu L; Gill R; Prichard M; Lesort M; Sztul E
    Neurobiol Dis; 2011 Jan; 41(1):11-22. PubMed ID: 20732421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disruption of Purkinje cell function prior to huntingtin accumulation and cell loss in an animal model of Huntington disease.
    Dougherty SE; Reeves JL; Lucas EK; Gamble KL; Lesort M; Cowell RM
    Exp Neurol; 2012 Jul; 236(1):171-8. PubMed ID: 22579526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcriptional alterations and chromatin remodeling in polyglutamine diseases.
    Helmlinger D; Tora L; Devys D
    Trends Genet; 2006 Oct; 22(10):562-70. PubMed ID: 16911843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonallele specific silencing of ataxin-7 improves disease phenotypes in a mouse model of SCA7.
    Ramachandran PS; Boudreau RL; Schaefer KA; La Spada AR; Davidson BL
    Mol Ther; 2014 Sep; 22(9):1635-42. PubMed ID: 24930601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interferon β induces clearance of mutant ataxin 7 and improves locomotion in SCA7 knock-in mice.
    Chort A; Alves S; Marinello M; Dufresnois B; Dornbierer JG; Tesson C; Latouche M; Baker DP; Barkats M; El Hachimi KH; Ruberg M; Janer A; Stevanin G; Brice A; Sittler A
    Brain; 2013 Jun; 136(Pt 6):1732-45. PubMed ID: 23518714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autophagy: polyQ toxic fragment turnover.
    Duncan C; Papanikolaou T; Ellerby LM
    Autophagy; 2010 Feb; 6(2):312-4. PubMed ID: 20104018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. α-Synuclein accumulates in huntingtin inclusions but forms independent filaments and its deficiency attenuates early phenotype in a mouse model of Huntington's disease.
    Tomás-Zapico C; Díez-Zaera M; Ferrer I; Gómez-Ramos P; Morán MA; Miras-Portugal MT; Díaz-Hernández M; Lucas JJ
    Hum Mol Genet; 2012 Feb; 21(3):495-510. PubMed ID: 22045698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A role for both wild-type and expanded ataxin-7 in transcriptional regulation.
    Ström AL; Forsgren L; Holmberg M
    Neurobiol Dis; 2005 Dec; 20(3):646-55. PubMed ID: 15936949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered p53 and NOX1 activity cause bioenergetic defects in a SCA7 polyglutamine disease model.
    Ajayi A; Yu X; Wahlo-Svedin C; Tsirigotaki G; Karlström V; Ström AL
    Biochim Biophys Acta; 2015; 1847(4-5):418-428. PubMed ID: 25647692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The ins and outs of a polyglutamine neurodegenerative disease: spinocerebellar ataxia type 1 (SCA1).
    Orr HT
    Neurobiol Dis; 2000 Jun; 7(3):129-34. PubMed ID: 10860780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic and Organelle Morphology Defects in Mice and Human Patients Define Spinocerebellar Ataxia Type 7 as a Mitochondrial Disease.
    Ward JM; Stoyas CA; Switonski PM; Ichou F; Fan W; Collins B; Wall CE; Adanyeguh I; Niu C; Sopher BL; Kinoshita C; Morrison RS; Durr A; Muotri AR; Evans RM; Mochel F; La Spada AR
    Cell Rep; 2019 Jan; 26(5):1189-1202.e6. PubMed ID: 30699348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteolytic cleavage of ataxin-7 promotes SCA7 retinal degeneration and neurological dysfunction.
    Guyenet SJ; Mookerjee SS; Lin A; Custer SK; Chen SF; Sopher BL; La Spada AR; Ellerby LM
    Hum Mol Genet; 2015 Jul; 24(14):3908-17. PubMed ID: 25859008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in Purkinje cell firing and gene expression precede behavioral pathology in a mouse model of SCA2.
    Hansen ST; Meera P; Otis TS; Pulst SM
    Hum Mol Genet; 2013 Jan; 22(2):271-83. PubMed ID: 23087021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.